Galapagos NV
GLPG
#4607
Rank
S$2.69 B
Marketcap
S$40.92
Share price
-2.70%
Change (1 day)
12.68%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -S$0.7 Billion

According to Galapagos NV's latest financial reports the company's current earnings are S$0.32 Billion. In 2024 the company made an earning of -S$7.47 Million, an increase over its 2023 earnings that were of -S$43.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.7 Billion9174.5%
2024 -S$7.47 Million-82.77%
2023 -S$43.32 Million-85.59%
2022 -S$0.31 Billion60.71%
2021 -S$0.19 Billion-60.08%
2020 -S$0.47 Billion-331.44%
2019 S$0.20 B-523.76%
2018 -S$47.79 Million-72.34%
2017 -S$0.18 Billion-329.59%
2016 S$75.25 M-144.3%
2015 -S$0.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
S$16.90 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$41.83 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.75 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$2.14 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-S$0.12 Billion-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.50 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.28 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$12.03 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$29.81 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA